The prevention of malaria

Primary Care - Clinics in Office Practice

Volumn 29, Issue 4, 2002, Pages 815-842

  Magill, Alan J ^a  

^a WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIDEPRESSANT AGENT; ANTIMALARIAL AGENT; ANXIOLYTIC AGENT; ATOVAQUONE PLUS PROGUANIL; CHLOROQUINE; DIETHYLTOLUAMIDE; DOXYCYCLINE; FLUOXETINE; HYDROXYCHLOROQUINE; INSECTICIDE; MEFLOQUINE; PAROXETINE; PRIMAQUINE; SEROTONIN UPTAKE INHIBITOR;

ABDOMINAL PAIN; ADOLESCENT; ADULT; AGED; ANXIETY DISORDER; CHILD; CHILD HEALTH CARE; CLINICAL TRIAL; DEPRESSION; DOUBLE BLIND PROCEDURE; DRUG CONTRAINDICATION; DRUG COST; DRUG INDICATION; EARLY DIAGNOSIS; FEMALE; GASTROINTESTINAL TOXICITY; GERIATRIC PATIENT; GLUCOSE 6 PHOSPHATE DEHYDROGENASE DEFICIENCY; HEADACHE; HEMOLYTIC ANEMIA; HIGH RISK POPULATION; HUMAN; INFECTION RISK; INSECT BITE; INSECT CONTROL; MAJOR CLINICAL STUDY; MALARIA; MALARIA CONTROL; MALARIA FALCIPARUM; MALE; MENTAL DISEASE; MOOD DISORDER; MULTICENTER STUDY; NAUSEA; NEUROTOXICITY; NIGHTMARE; PARASITE; PATIENT COMPLIANCE; PHOTOSENSITIVITY DISORDER; PHOTOTOXICITY; PLASMODIUM; PRACTICE GUIDELINE; PREGNANCY; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; PROTECTIVE CLOTHING; REVIEW; SEIZURE; SLEEP DISORDER; SUICIDAL BEHAVIOR; TOOTH COLOR; TOOTH DISEASE; TRAVEL; VERTIGO; VOMITING;

ANIMALS; ANOPHELES; ANTIMALARIALS; BEDDING AND LINENS; CHEMOPREVENTION; DEVELOPING COUNTRIES; HUMANS; INSECT BITES AND STINGS; INSECT REPELLENTS; MALARIA; PRIMARY HEALTH CARE; PRIMARY PREVENTION; PROTECTIVE CLOTHING; TRAVEL;

EID: 0036955491     PISSN: 00954543     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0095-4543(02)00042-8     Document Type: Review

References (136)

1. Ross R. Memoirs with a full account of the great malaria problem and its solution. London: Murray; 1923.
2. Taylor TE, Strickland GT. Malaria. In: Strickland GT, editor. Hunter's tropical medicine and emerging infectious diseases. 8th edition. Philadelphia: WB Saunders; 2000. p. 614.
3. Morbidity and Mortality Weekly Report. Available at: http://www.cdc.gov/mmwr. Accessed October 2002.
4. Berger A. Science commentary: protection against malaria. BMJ 1998;317:1508.
5. Kain KC, Harrington MA, Tennyson S, et al. Imported malaria: prospective analysis of problems in diagnosis and management. Clin Infect Dis 1998;27:142-9.
6. Roth HP, Caron HS. Accuracy of doctors' estimates and patients' statements on adherence to a drug regimen. Clin Pharmacol Ther 1978;23:361-70.
7. Croft AM, Garner P. Mefloquine for preventing malaria in non-immune adult travellers. (Cochrane Review) In: The Cochrane Library, Issue 3. Oxford: Update Software; 2002.
8. Kain KC, Shanks GD, Keystone JS. Malaria chemoprophylaxis in the age of drug resistance. I. Currently recommended drug regimens. Clin Infect Dis 2001:33:226-34.
9. O'Neill PM, Bray PG, Hawley SR, et al. 4-Aminoquinolines-past, present, and future: a chemical perspective. Pharmacol Ther 1998;77:29-58.
10. Palmer KJ, Holliday SM, Brogden RN. Mefloquine: a review of its antimalarial activity, pharmacokinetic properties and therapeutic efficacy. Drugs 1993;45:430-75.
11. Schlagenhauf P. Mefloquine for malaria chemoprophylaxis 1992-1998: a review. J Travel Med 1999;6:122-33.
12. Shanks GD, Kain KC, Keystone JS. Malaria chemoprophylaxis in the age of drug resistance. II. Drugs that may be available in the future. Clin Infect Dis 2001;33:381-85.
13. Wongsrichanalai C, Pickard AL, Wernsdorfer WH, et al. Epidemiology of drug-resistant malaria. Lancet Infect Dis 2002;2:209-18.
14. Committee to Advise on Tropical Medicine and Travel (CATMAT), Laboratory for Disease Control. Canadian recommendations for the prevention and treatment of malaria among international travellers. Can Commun Dis Rep 2000;26(Suppl 2):1-48.
15. Bradley DJ, Bannister B. Guidelines for malaria prevention in travellers from the United Kingdom for 2001. Commun Dis Public Health 2001;4:84-101.
16. Baird J. Brief exposure prophylaxis. In: Schlagenhauf P, editor. Travelers' malaria. Hamilton: BC Decker; 2001. p. 532.
17. Hatz C, Krause E, Grundmann H. Travel advice: a study among Swiss and German general practitioners. Trop Med Int Health 1997;2:6-12.
18. Kain KC, MacPherson DW, Kelton T, et al. Malaria deaths in visitors to Canada and in Canadian travellers: a case series. CMAJ 2001;164:654-9.
19. Keystone JS, Dismukes R, Sawyer L, et al. Inadequacies in health recommendations provided for international travelers by North American travel health advisors. J Travel Med 1994;1:72-8.
20. Wongsrichanalai C, Sirichaisinthop J, Karwacki JJ, et al. Drug resistant malaria on the Thai-Myanmar and Thai-Cambodian borders. Southeast Asian J Trop Med Public Health 2001;32:41-9.
21. Centers for Disease Control and Prevention. Health information for the international traveler 2001-2002. Atlanta: US Department of Health and Human Resources, Public Health Service; 2001.
22. World Health Organization. International travel and health. www.who.int/ith/. Accessed 2002.
23. American Society of Tropical Medicine & Hygiene. Available at: http://www.astmh.org. Accessed October 2002.
24. International Society of Travel Medicine. Available at: http://www.istm.org. Accessed October 2002.
25. Behrens RH, Phillips-Howard PA. What do travellers know about malaria? Lancet 1989;2:1395-6.
26. Genton B, Behrens RH. Specialized travel consultation, part I: travelers' prior knowledge. J Travel Med 1994;1:8-12.
27. Genton B, Behrens RH. Specialized travel consultation, part II: acquiring knowledge. J Travel Med 1994;1:13-15.
28. Greenberg adverse event, Lobel HO. Mortality from Plasmodium falciparum malaria in travelers from the United States, 1959 to 1987. Ann Intern Med 1990;113:326-7.
29. Mittelholzer ML, Wall M, Steffen R, et al. Malaria prophylaxis in different age groups. J Travel Med 1996;3:219-23.
30. Stauffer W, Kamat D, Magill A. Traveling with infants and children. Part IV. Insect avoidance and malaria prevention. J Travel Med 2002;3:(in press).
31. Kager PA, Wetsteyn JC. [Severe Plasmodium falciparum malaria in pregnancy: a threat to mother and child.] Ned Tijdschr Geneeskd 2000;144:863-4.
32. Subramanian D, Moise KJ Jr, White AC Jr. Imported malaria in pregnancy: report of four cases and review of management. Clin Infect Dis 1992;15:408-13.
33. Wetsteyn JC, de Geus A. Falciparum malaria, imported into the Netherlands, 1979-1988. II. Clinical features. Trop Geogr Med 1995;47:97-102.
34. Ansell J, Hamilton KA, Pinder M, et al. Short-range attractiveness of pregnant women to Anopheles gambiae mosquitoes. Trans R Soc Trop Med Hyg 2002;96:113-6.
35. Lindsay S, Ansell J, Selman C, et al. Effect of pregnancy on exposure to malaria mosquitoes. Lancet 2000;355:1972.
36. Martinez Espinosa F, Alecrim WD, Daniel-Ribeiro CT. Attraction of mosquitoes to pregnant women. Lancet 2000;356:685.
37. Phillips-Howard PA, Steffen R, Kerr L, et al. Safety of mefloquine and other antimalarial agents in the first trimester of pregnancy. J Travel Med 1998;5:121-26.
38. Phillips-Howard PA, Wood D. The safety of antimalarial drugs in pregnancy. Drug Saf 1996;14:131-45.
39. Samuel BU, Barry M. The pregnant traveler. Infect Dis Clin North Am 1998;12:325.
40. Smoak BL, Writer JV, Keep LW, et al. The effects of inadvertent exposure of mefloquine chemoprophylaxis on pregnancy outcomes and infants of US Army servicewomen. J Infect Dis 1997;176:831-3.
41. Vanhauwere B, Maradit H, Kerr L. Post-marketing surveillance of prophylactic mefloquine (Lariam) use in pregnancy. Am J Trop Med Hyg 1998;58:17-21.
42. Fradin MS. Mosquitoes and mosquito repellents: a clinician's guide. Ann Intern Med 1998;128:931-40.
43. Lillie TH, Schreck CE, Rahe AJ. Effectiveness of personal protection against mosquitoes in Alaska. J Med Entomol 1988;25:475-8.
44. Copeland RS, Walker TW, Robert LL, et al. Response of wild Anopheles funestus to repellent-protected volunteers is unaffected by malaria infection of the vector. J Am Mosq Control Assoc 1995;11:438-40.
45. Frances SP, Cooper RD, Popat S, et al. Field evaluation of repellents containing deet and AI3-37220 against Anopheles koliensis in Papua New Guinea. J Am Mosq Control Assoc 2001;17:42-44.
46. Frances SP, Klein TA, Hildebrandt DW, et al. Laboratory and field evaluation of deet, CIC-4, and AI3-37220 against Anopheles dirus (Diptera: Culicidae) in Thailand. J Med Entomol 1996;33:511-15.
47. Govere J, Braack LE, Durrheim DN, et al. Repellent effects on Anopheles arabiensis biting humans in Kruger Park, South Africa. Med Vet Entomol 2001;15:287-92.
48. Govere J, Durrheim DN, Baker L, et al. Efficacy of three insect repellents against the malaria vector Anopheles arabiensis. Med Vet Entomol 2000;14:441-4.
49. Le Goff G, Robert V, Carnevale P. [Evaluation of a DEET-based repellent on 3 vectors of malaria in central Africa.] Sante 1994;4:269-73.
50. Robert LL, Hallam JA, Seeley DC, et al. Comparative sensitivity of four Anopheles (Diptera: Culicidae) to five repellents. J Med Entomol 1991;28:417-20.
51. Robert LL, Schneider I, Wirtz RA. Deet and permethrin as protectants against malaria-infected and uninfected Anopheles stephensi mosquitoes. J Am Mosq Control Assoc 1991;7:304-6.
52. Walker TW, Robert LL, Copeland RA, et al. Field evaluation of arthropod repellents, deet and a piperidine compound, AI3-37220, against Anopheles funestus and Anopheles arabiensis in western Kenya. J Am Mosq Control Assoc 1996;12:172-6.
53. Schoepke A, Steffen R, Gratz N. Effectiveness of personal protection measures against mosquito bites for malaria prophylaxis in travelers. J Travel Med 1998;5:188-92.
54. Joy RJ. Malaria in American troops in the South and Southwest Pacific in World War II. Med Hist 1999;43:192-207.
55. Fradin MS, Day JF. Comparative efficacy of insect repellents against mosquito bites. N Engl J Med 2002;347:13-18.
56. Malaria deaths following inappropriate malaria chemoprophylaxis-United States, 2001. MMWR Morb Mortal Wkly Rep 2001;50:597-9.
57. Lobel HO, Miani M, Eng T, et al. Long-term malaria prophylaxis with weekly mefloquine. Lancet 1993;341:848-51.
58. Steffen R, Fuchs E, Schildknecht J, et al. Mefloquine compared with other malaria chemoprophylactic regimens in tourists visiting east Africa. Lancet 1993;341:1299-1303.
59. Behrens RH, Taylor RB, Pryce DI, et al. Chemoprophylaxis compliance in travelers with malaria. J Travel Med 1998;5:92-4.
60. Cobelens FG, Leentvaar-Kuijpers A. Compliance with malaria chemoprophylaxis and preventative measures against mosquito bites among Dutch travellers. Trop Med Int Health 1997;2:705-13.
61. Dorsey G, Gandhi M, Oyugi JH, et al. Difficulties in the prevention, diagnosis, and treatment of imported malaria. Arch Intern Med 2000;160:2505-10.
62. Froude JR, Weiss LM, Tanowitz HB, et al. Imported malaria in the Bronx: review of 51 cases recorded from 1986 to 1991. Clin Infect Dis 1992;15:774-80.
63. Gyorkos TW, Svenson JE, Maclean JD, et al. Compliance with antimalarial chemoprophylaxis and the subsequent development of malaria: a matched case-control study. Am J Trop Med Hyg 1995;53:511-7.
64. Nuesch R, Scheller M, Gyr N. Hospital admissions for malaria in Basel, Switzerland: an epidemiological review of 150 cases. J Travel Med 2000;7:95-7.
65. Raglio A, Parea M, Lorenzi N, et al. Ten-year experience with imported malaria in Bergamo, Italy. J Travel Med 1994;1:152-5.
66. Winters RA, Murray HW. Malaria-the mime revisited: fifteen more years of experience at a New York City teaching hospital. Am J Med 1992;93:243-6.
67. Armengaud M. Arguments against chemoprophylaxis in areas at low risk for chloroquine-resistant Plasmodium falciparum. J Travel Med 1995;2:4-5.
68. Jelinek T, Bluml A, Loscher T, et al. Assessing the incidence of infection with Plasmodium falciparum among international travelers. Am J Trop Med Hyg 1998;59:35-7.
69. Jelinek T, Schulte C, Behrens R, et al. Imported Falciparum malaria in Europe: sentinel surveillance data from the European network on surveillance of imported infectious diseases. Clin Infect Dis 2002;34:572-6.
70. Steffen R. Strategies of malaria prevention in nonimmune visitors to endemic countries. In: Schlagenhauf P, editor. Travelers' malaria. Hamilton: BC Decker; 2001. p. 149-62.
71. Jelinek T. Evidence of malaria exposure in travelers. In: Schlagenhauf P, editor. Travelers' malaria. Hamilton: BC Decker; 2001. p. 94-103.
72. Nothdurft HD, Jelinek T, Bluml A, et al. Seroconversion to circumsporozoite antigen of Plasmodium falciparum demonstrates a high risk of malaria transmission in travelers to East Africa. Clin Infect Dis 1999;28:641-2.
73. Schlagenhauf P. Standby emergency treatment by travelers. In: Schlagenhauf P, editor. Travelers' malaria. Hamilton: BC Decker; 2001. p. 446-62.
74. Public Health Foundation Training Resource Center. Available at: http://bookstore.ph-f.org. Accessed October 2002.
75. The Yellow Book (Health Information for International Travel) 2001-2002. Available at: http://www.cdc.gov/travel/yb/index.htm. Accessed October 2002.
76. National Center for Infectious Diseases, Travelers' Health Diseases-Malaria. Available at: http://www.cdc.gov/travel/diseases.htm#malaria. Accessed October 2002.
77. World Health Organization. International Travel and Health. Chapter 7. Malaria. Available at: http://www.who.int/ith/chapter07_01.html. Accessed October 2002.
78. Newton P, Proux S, Green M, et al. Fake artesunate in southeast Asia. Lancet 2001;357:1948-50.
79. Newton PN, White NJ, Rozendaal JA, et al. Murder by fake drugs. BMJ 2002;324:800.
80. Rozendaal J. Fake antimalaria drugs in Cambodia. Lancet 2001;357:890.
81. Childhood chloroquine poisonings-Wisconsin and Washington. MMWR Morb Mortal Wkly Rep 1988;37:437-9.
82. Loney PD, Walling AD. Chloroquine overdosage in infancy: a case report. Am Fam Physician 1989;40:164-6.
83. Moran JS, Bernard KW. The spread of chloroquine-resistant malaria in Africa: implications for travelers. JAMA 1989;262:245-8.
84. Moran JS, Bernard KW, Greenberg adverse event, et al. Failure of chloroquine treatment to prevent malaria in Americans in West Africa. JAMA 1987;258:2376-7.
85. Schlagenhauf P, Steffen R. Neuropsychiatric events and travel: do antimalarials play a role? J Travel Med 2000;7:225-6.
86. Lobel HO, Kozarsky PE. Update on prevention of malaria for travelers. JAMA 1997;278:1767-71.
87. Schlagenhauf P. Mefloquine, methodologies, and the media. J Travel Med 1996;3:197-9.
88. Overbosch D, Schilthuis H, Bienzle U, et al. Atovaquone-proguanil versus mefloquine for malaria prophylaxis in nonimmune travelers: results from a randomized, double-blind study. Clin Infect Dis 2001;33:1015-21.
89. Phillips MA, Kass RB. User acceptability patterns for mefloquine and doxycycline malaria chemoprophylaxis. J Travel Med 1996;3:40-45.
90. Schlagenhauf P, Steffen R, Lobel H, et al. Mefloquine tolerability during chemoprophylaxis: focus on adverse event assessments, stereochemistry and compliance. Trop Med Int Health 1996;1:485-94.
91. Schwartz E, Potasman I, Rotenberg M, et al. Serious adverse events of mefloquine in relation to blood level and gender. Am J Trop Med Hyg 2001;65:189-92.
92. Simpson J, Aarons L, Price R, et al. The influence of body weight on the pharmacokinetics of mefloquine. Br J Clin Pharmacol 2002;53:337-8.
93. Barrett PJ, Emmins PD, Clarke PD, et al. Comparison of adverse events associated with use of mefloquine and combination of chloroquine and proguanil as antimalarial prophylaxis: postal and telephone survey of travellers. BMJ 1996;313:525-8.
94. Huzly D, Schonfeld C, Beuerle W, et al. Malaria chemoprophylaxis in German tourists: a prospective study on compliance and adverse reactions. J Travel Med 1996;3:148-55.
95. Benjamin M, Olmstead D. Lariam and suicide: the anti-malaria drug is cited in several cases. Available at www.newsday.com. Accessed May 2002.
96. Barsky AJ, Saintfort R, Rogers MP, et al. Nonspecific medication side effects and the nocebo phenomenon. JAMA 2002;287:622-7.
97. Na-Bangchang K, Karbwang J, Palacios PA, et al. Pharmacokinetics and bioequivalence evaluation of three commercial tablet formulations of mefloquine when given in combination with dihydroartemisinin in patients with acute uncomplicated falciparum malaria. Eur J Clin Pharmacol 2000;55:743-8.
98. Weidekamm E, Rusing G, Caplain H, et al. Lack of bioequivalence of a generic mefloquine tablet with the standard product. Eur J Clin Pharmacol 1998;54:615-9.
99. Geneva Pharm MQ approval. In: 2002.
100. Beallor C, Kain K. Doxycycline. In: Schlagenhauf P, editor. Travelers' malaria. Hamilton: BC Decker; 2001. p. 210-8.
101. Jaspersen D. Drug-induced oesophageal disorders: pathogenesis, incidence, prevention and management. Drug Saf 2000;22:237-49.
102. Morris TJ, Davis TP. Doxycycline-induced esophageal ulceration in the U.S. Military service. Mil Med 2000;165:316-9.
103. Schuhwerk M, Behrens RH. Doxycycline as first line malarial prophylaxis: how safe is it? J Travel Med 1998;5:102.
104. Baird JK, Fryauff DJ, Basri H, et al. Primaquine for prophylaxis against malaria among nonimmune transmigrants in Irian Jaya, Indonesia. Am J Trop Med Hyg 1995;52:479-84.
105. Baird JK, Lacy MD, Basri H, et al. Randomized, parallel placebo-controlled trial of primaquine for malaria prophylaxis in Papua, Indonesia. Clin Infect Dis 2001;33:1990-7.
106. Fryauff DJ, Baird JK, Basri H, et al. Randomised placebo-controlled trial of primaquine for prophylaxis of falciparum and vivax malaria. Lancet 1995;346:1190-3.
107. Schwartz E, Regev-Yochay G. Primaquine as prophylaxis for malaria for nonimmune travelers: a comparison with mefloquine and doxycycline. Clin Infect Dis 1999;29:1502-6.
108. Soto J, Toledo J, Rodriquez M, et al. Primaquine prophylaxis against malaria in nonimmune Colombian soldiers: efficacy and toxicity. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 1998;129:241-4.
109. Weiss WR, Oloo AJ, Johnson A, et al. Daily primaquine is effective for prophylaxis against falciparum malaria in Kenya: comparison with mefloquine, doxycycline, and chloroquine plus proguanil. J Infect Dis 1995;171:1569-75.
110. Svenson JE, MacLean JD, Gyorkos TW, et al. Imported malaria: clinical presentation and examination of symptomatic travelers. Arch Intern Med 1995;155:861-8.
111. Svenson JE, Gyorkos TW, MacLean JD. Diagnosis of malaria in the febrile traveler. Am J Trop Med Hyg 1995;53:518-21.
112. Moore TA, Tomayko JF Jr, Wierman AM, et al. Imported malaria in the 1990s: a report of 59 cases from Houston. Tex Arch Fam Med 1994;3:130-6.
113. Walzer PD, Gibson JJ, Schultz MG. Malaria fatalities in the United States. Am J Trop Med Hyg 1974;23:328-33.
114. Jensenius M, Ronning EJ, Blystad H, et al. Low frequency of complications in imported falciparum malaria: a review of 222 cases in south-eastern Norway. Scand J Infect Dis 1999;31:73-8.
115. Magill AJ. Fever in the returned traveler. Infect Dis Clin North Am 1998;12:445-69.
116. Milne LM, Kyi MS, Chiodini PL, et al. Accuracy of routine laboratory diagnosis of malaria in the United Kingdom. J Clin Pathol 1994;47:740-2.
117. Doherty JF, Grant AD, Bryceson AD. Fever as the presenting complaint of travellers returning from the tropics. QJM 1995;88:277-81.
118. MacLean JLR, Ward B. Fever from the tropics. Travel Medicine Advisor 1994;5:1-14.
119. Day JH, Behrens RH. Delay in onset of malaria with mefloquine prophylaxis. Lancet 1995;345:398.
120. Klement E, Chauveheid MP, Thellier M, et al. Subacute clinical forms of Plasmodium falciparum malaria in travelers receiving chloroquine-proguanil prophylaxis. Clin Infect Dis 2001;33:e1-2.
121. Lewis SJ, Davidson RN, Ross EJ, et al. Severity of imported falciparum malaria: effect of taking antimalarial prophylaxis. BMJ 1992;305:741.
122. Reyburn H, Behrens RH, Warhurst D, et al. The effect of chemoprophylaxis on the timing of onset of falciparum malaria. Trop Med Int Health 1998;3:281-5.
123. Stuiver PC, van Rijswijk JB, Visser LG. Delayed onset of malignant tertian malaria through the inappropriate use of doxycycline: another threat to patients returning from malarious areas. J Travel Med 1996;3:193.
124. D'Acremont V, Landry P, Darioli R, et al. Treatment of imported malaria in an ambulatory setting: prospective study. BMJ 2002;324:875.
125. Treatment with quinidine gluconate of persons with severe Plasmodium falciparum infection: discontinuation of parenteral quinine from CDC Drug Service. MMWR Recomm Rep 1991;40:21.
126. Miller KD, Greenberg adverse event, Campbell CC. Treatment of severe malaria in the United States with a continuous infusion of quinidine gluconate and exchange transfusion. N Engl J Med 1989;321:65.
127. Phillips RE, Warrell DA, White NJ, et al. Intravenous quinidine for the treatment of severe falciparum malaria: clinical and pharmacokinetic studies. N Engl J Med 1985;312:1273.
128. Availability of parenteral quinidine gluconate for treatment of severe or complicated malaria. MMWR Morb Mortal Wkly Rep 1996;45:494.
129. Humar A, Sharma S, Zoutman D, et al. Fatal falciparum malaria in Canadian travellers. CMAJ 1997;156:1165.
130. Rosenthal PJ, Petersen C, Geertsma FR, et al. Availability of intravenous quinidine for falciparum malaria. N Engl J Med 1996;335:138.
131. Availability and use of parenteral quinidine gluconate for severe or complicated malaria. MMWR Morb Mortal Wkly Rep 2000;49:1138.
132. Frances SP, Cooper RD, Sweeney AW. Laboratory and field evaluation of the repellents deet, CIC-4, and AI3-37220 against Anopheles farauti (Diptera: Culicidae) in Australia. J Med Entomol 1998;35:690.
133. Frances SP, Eamsila C, Pilakasiri C, et al. Effectiveness of repellent formulations containing deet against mosquitoes in northeastern Thailand. J Am Mosq Control Assoc 1996;12:331.
134. Frances SP, Eikarat N, Sripongsai B, et al. Response of Anopheles dirus and Aedes albopictus to repellents in the laboratory. J Am Mosq Control Assoc 1993;9:474.
135. Balocco R, Bonati M. Mefloquine prophylaxis against malaria for female travellers of childbearing age. Lancet 1992;340:309-10.
136. Philips-Howard PA, Stefen R, Kerr L, et al. Safety of mefloquine and other antimalarial agents in the first trimester of pregnancy. J Travel Med 1998;5(3):121-6.